10-K: Natural Alternatives International Faces Going Concern Doubt

Natural Alternatives International, Inc. (NAI) reported continued net losses and negative operating cash flows, with a forecasted inability to meet debt covenants, raising substantial doubt about its ability to continue as a going concern.

Summary

• Natural Alternatives International, Inc. (NAI) reported a net loss of $20.7 million for the fiscal year ended June 30, 2026, an increase from a net loss of $13.6 million in the prior year.
• The company's operating cash flows were negative at $8.9 million for fiscal year 2026.
• NAI anticipates it will not be able to comply with a fixed charge coverage ratio covenant for its domestic operations for the nine months ending September 30, 2026, due to a significant customer's downward revision of projected orders.
• Substantial doubt exists about the company's ability to continue as a going concern, prompting management to explore strategic alternatives including a potential sale of the company.
• The company is pursuing actions such as selling its corporate headquarters and Carlsbad manufacturing facility to improve liquidity and reduce debt.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to significant financial challenges, including continued net losses, negative operating cash flows, and a forecasted inability to meet debt covenants, raising substantial doubt about the company's ability to continue as a going concern.

Positives

• Net sales increased by 10% to $142.5 million in fiscal year 2026 compared to $129.9 million in fiscal year 2025.
• Private-label contract manufacturing sales increased by 11% to $134.6 million, driven by increased orders from a major customer and other existing clients.
• The company has secured new credit facilities with Legacy Corporate Lending, LLC and UBS Switzerland AG to provide liquidity.
• Management is actively pursuing strategic alternatives, including the sale of assets and potential mergers or acquisitions, to enhance shareholder value.

Negatives

• The company reported a net loss of $20.7 million for fiscal year 2026, a significant increase from $13.6 million in fiscal year 2025.
• Operating cash flow was negative at $8.9 million for fiscal year 2026.
• A substantial doubt about the company's ability to continue as a going concern has been raised by management and the independent auditor.
• NAI anticipates non-compliance with a key debt covenant (fixed charge coverage ratio) in the upcoming reporting period.
• A non-cash impairment charge of $10.4 million was recognized for the Carlsbad, California manufacturing facility.
• The company is listing its corporate headquarters and Carlsbad manufacturing facility for sale to improve liquidity.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to continued net losses, negative operating cash flows, and forecasted inability to meet debt covenant requirements.
• The company's reliance on a few large customers for a significant portion of its revenue (28% from the largest customer in FY2026) poses a risk if these customers reduce orders or terminate relationships.
• The company anticipates non-compliance with a fixed charge coverage ratio covenant in its new credit facility, potentially leading to default if waivers or amendments are not obtained.
• The sale of key assets (corporate headquarters and Carlsbad manufacturing facility) may not be completed on favorable terms or within a desired timeframe.
• Global economic instability, including supply chain issues, inflation, and geopolitical tensions, could adversely affect the company's results.
• Increased competition in the nutritional supplement industry could lead to price reductions, reduced profit margins, or loss of market share.

Future Outlook

The company anticipates a net loss for fiscal year 2027, despite an expected increase in overall sales compared to fiscal year 2026. Management is focused on growing sales, consolidating facilities, and exploring strategic alternatives to improve financial performance and mitigate going concern risks.

Management Comments

• Management believes unlocking the capital currently held in the Carlsbad facility will allow the Company to extinguish the outstanding term-note on this property, reduce persistent excess capacity in our contract manufacturing segment, and better size the Company for sustainable growth.
• Management believes production can be effectively consolidated into our Vista, California manufacturing facility with no disruptions to production of customers' products.
• Management has prepared cash flow projections incorporating these plans, as well as projected sales growth reflecting our best estimates of future operating performance and liquidity needs.
• Management believes these plans will allow the Company to mitigate the current conditions that have raised substantial doubt about the Companys ability to continue as a going concern.

Industry Context

StockSavvy.ai notes that the nutritional supplement industry is highly competitive and fragmented. NAI's challenges, including customer concentration and operational costs, are exacerbated by broader industry trends like supply chain disruptions and inflationary pressures.

Comparison to Industry Standards

• The company's net sales growth of 10% in FY2026 is positive, but the concurrent increase in net loss and negative operating cash flow indicates significant operational inefficiencies or cost pressures not aligned with industry best practices for profitability.
• The substantial doubt about NAI's ability to continue as a going concern is a critical concern, as most healthy companies in the sector maintain strong liquidity and positive cash flows.
• The company's strategy to sell key assets and explore strategic alternatives is a reactive measure often seen in companies facing financial distress, contrasting with proactive growth strategies of financially robust industry players.
• The significant impairment charge of $10.4 million suggests potential overvaluation of assets or a decline in the value of its operational infrastructure, which is not typical for well-managed companies in stable or growing markets.

Legal Proceedings

• A class action and PAGA lawsuit filed by three former employees has a tentative settlement agreement of $1.25 million, with final court approval expected in February 2027.

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern issues, potential stock price decline, and the possibility of dilution if new capital is raised.
• Creditors face increased risk due to the company's forecasted inability to meet debt covenants and its reliance on new credit facilities.
• Employees may face uncertainty regarding job security given the company's financial situation and potential strategic alternatives, including a sale.
• Suppliers may face risks related to potential changes in order volumes or payment terms due to the company's financial challenges.

Next Steps

• Management is actively marketing the corporate headquarters and Carlsbad manufacturing facility for sale.
• The company is exploring strategic alternatives, including potential mergers, acquisitions, joint ventures, or a strategic sale.
• Management is focused on growing sales through existing and new customer relationships.
• Cost containment and reduction opportunities are being evaluated.
• The company anticipates a net loss for fiscal year 2027 and is preparing for potential non-compliance with debt covenants.

Key Dates

Recommendation

The company's severe financial distress, including substantial doubt about its going concern status, significant net losses, negative cash flow, and impending debt covenant non-compliance, presents a high level of risk for investors. While strategic actions are being taken, the immediate outlook is negative, warranting a sell recommendation.

Keywords

Nutritional Supplements, Contract Manufacturing, Beta-Alanine, CarnoSyn, Financial Health, Going Concern, Debt Covenants, Asset Sale